The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma

Not yet recruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

December 16, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2029

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

OTHER

No intervention (observational study)

no intervention(observational study)

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER

NCT06750159 - The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter